Overview

A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
0
Participant gender:
All
Summary
A dose ranging study to evaluate safety and efficacy of bromfenac ophthalmic solution in dry eye disease.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Bausch & Lomb Incorporated
Treatments:
Bromfenac
Ophthalmic Solutions
Pharmaceutical Solutions
Criteria
Inclusion Criteria:

- Be of either gender and any race 18 years or older

Exclusion Criteria:

- Have a local or systemic disease that could interfere with the assessment of safety or
efficacy or that is likely to result in early discontinuation from the study